Tokyo, Japan

Shiro Kataoka

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 132(Granted Patents)


Location History:

  • Maebashi, JP (1989)
  • Gunma, JP (2006)
  • Takasaki, JP (2007 - 2009)
  • Shibuya-ku, JP (2011 - 2012)
  • Tokyo-to, JP (2011 - 2015)
  • Tokyo, JP (2008 - 2017)

Company Filing History:


Years Active: 1989-2017

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: An Insight into the Innovations of Shiro Kataoka

Introduction

Shiro Kataoka is a prominent inventor based in Tokyo, Japan, known for his groundbreaking contributions to medical technology, particularly in cancer treatment. With a remarkable portfolio of 12 patents, Kataoka's innovative work has the potential to significantly impact therapeutic approaches to combating cancer.

Latest Patents

One of his latest patents focuses on Anti-CD98 antibody processes. This invention involves a human antibody or a functional fragment that specifically binds to CD98, derived from the cell membrane of cancer cells. It forms a complex with a protein that has amino acid transporter activity, such as LAT1. The unique feature of this antibody is its ability to bind to CD98 in a dimer form alongside LAT1 on the surface of cancer cells. This mechanism allows it to specifically target cancer cells expressing CD98, employing the immune system's mechanisms like Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) or Complement-Dependent Cytotoxicity (CDC). Moreover, it inhibits the uptake of amino acids via LAT1, thereby suppressing the growth of cancer cells. This innovation promises an effective preventive and therapeutic agent for various cancers, with the advantage of being specific to cancer and minimizing side effects.

Career Highlights

Shiro Kataoka's career has been marked by significant affiliations with notable companies, including Kyowa Hakko Kirin Co., Limited and Kirin Beer Kabushiki Kaisha. His roles at these companies have allowed him to leverage his expertise in biotechnology and contribute to the advancement of medical science.

Collaborations

Throughout his career, Kataoka has collaborated with esteemed professionals, including Tomoyuki Tahara and Yoshikatsu Kanai. These collaborations have undoubtedly played a crucial role in enriching his research and patent development, fostering an environment of innovation and scientific exploration.

Conclusion

Shiro Kataoka's inventive spirit and commitment to medical advancement are evident through his patents and collaborative efforts. With a strong focus on developing targeted therapies for cancer, his work not only showcases the power of innovation but also highlights the importance of collaboration in the field of biomedical research. As the landscape of cancer treatment continues to evolve, Kataoka's contributions will remain significant in shaping future strategies against this formidable disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…